Preclinical evidence for management of thrombocytopenia associated with bromodomain extra-terminal (BET) inhibition therapy.
2018
e24207Background: Thrombocytopenia is a potential dose-limiting toxicity associated with many oncology agents including BET inhibitors (BETi). Thrombocytopenia in rats closely mirrors clinical dose...
-
Correction
-
Source
-
Cite
-
Save
-
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI